Inhibitory effects of the combination of rapamycin with gemcitabine plus paclitaxel on the growth of pancreatic cancer tumors
Yuri Jobu(Kōchi University), Keisuke Taniuchi(Kōchi University)
Cited by 3
Related Papers
ARHGEF4 predicts poor prognosis and promotes cell invasion by influencing ERK1/2 and GSK-3α/β signaling in pancreatic cancer
|International Journal of Oncology|2018|11